Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 6Lymphoma 5Multiple Myeloma 3Waldenstrom Macroglobulinemia 2Lymphoma, Follicular 2Leukemia 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Burkitt Lymphoma 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoglobulin Light-chain Amyloidosis 1Head and Neck Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 2tremelimumab 1motexafin gadolinium 1lenvatinib 1ispinesib 1durvalumab 1X-Rays 1Specimen Handling 1Sorafenib 1Radiotherapy 1Radiosurgery 1Radiofrequency Ablation 1Platinum 1Phantoms, Imaging 1Ondansetron 1Mitomycin 1Interferon-alpha 1Gemcitabine 1Embolization, Therapeutic 1Doxorubicin 1Dexamethasone 1Cisplatin 1Capecitabine 1CF regimen 1Bone Density 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Hepatocellular × Interferon-alpha × Clear all
NCT01834963 2018-05-18

P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma.

Kansai Hepatobiliary Oncology Group

Phase 2 Unknown
66 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡